Markets:

Overview

News

Currencies

International

Treasuries

CollPlant Biotechnologies Ltd. - Ordinary Shares (NQ:CLGN)

1.410 -0.060 (-4.08%)

Streaming Delayed Price Updated: 3:59 PM EST, Jan 21, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about CollPlant Biotechnologies Ltd. - Ordinary Shares

< Previous 1 2 Next >

CLGN Stock Crashed 14% Today – Disappointing Earnings, Workforce Reduction Plan Draws Investor Attention ↗

November 26, 2025

The firm reported revenue of $77,000 for the three months ended September, above the $4,000 reported in the corresponding quarter of 2024, but below an analyst estimate of $5.03 million, according to...

Via Stocktwits

Topics Artificial Intelligence Workforce

CollPlant Biotechnologies Ltd (NASDAQ:CLGN) Plummets 10.7% on Q3 Earnings and Revenue Miss ↗

November 26, 2025

CollPlant stock plunges 10.7% after Q3 2025 earnings miss, with revenue of $80k far below the $4.94 million estimate.

Via Chartmill

Topics Earnings

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

September 30, 2025

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

August 21, 2025

Via Benzinga

What's Next: CollPlant Biotechnologies's Earnings Preview ↗

August 19, 2025

Via Benzinga

Earnings Preview: CollPlant Biotechnologies ↗

May 27, 2025

Via Benzinga

CollPlant Biotechnologies's Earnings: A Preview ↗

November 26, 2024

Via Benzinga

Cracking The Code: Understanding Analyst Reviews For CollPlant Biotechnologies ↗

August 21, 2024

Via Benzinga

Analyst Expectations For CollPlant Biotechnologies's Future ↗

August 21, 2025

Via Benzinga

CollPlant Biotechnologies Ltd (NASDAQ:CLGN) Q2 2025 Earnings Fall Significantly Short of Estimates ↗

August 20, 2025

CollPlant (CLGN) Q2 2025 results miss analyst estimates, with revenue of $180K far below expectations. Shares fell in pre-market trading on the earnings disappointment.

Via Chartmill

Earnings Scheduled For August 20, 2025 ↗

August 20, 2025

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

June 09, 2025

Via Benzinga

Recap: CollPlant Biotechnologies Q3 Earnings ↗

November 29, 2023

Via Benzinga

Dow Edges Higher; Dell Shares Fall After Q1 Results ↗

May 30, 2025

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Friday's Intraday Session ↗

May 30, 2025

Via Benzinga

Nasdaq Down 100 Points; Chicago PMI Dips In May ↗

May 30, 2025

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

May 30, 2025

Via Benzinga

Why UiPath Shares Are Trading Higher By Over 13%; Here Are 20 Stocks Moving Premarket ↗

May 30, 2025

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

May 29, 2025

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

May 28, 2025

Via Benzinga

Williams Companies To Rally Over 11%? Here Are 10 Top Analyst Forecasts For Wednesday ↗

May 28, 2025

Via Benzinga

Earnings Scheduled For May 28, 2025 ↗

May 28, 2025

Via Benzinga

Earnings Scheduled For March 26, 2025 ↗

March 26, 2025

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

November 27, 2024

Via Benzinga

Earnings Scheduled For November 27, 2024 ↗

November 27, 2024

Via Benzinga

CLGN Stock Earnings: CollPlant Biotechnologies Beats EPS, Misses Revenue for Q2 2024 ↗

August 20, 2024

CLGN stock results show that CollPlant Biotechnologies beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.

Via InvestorPlace

CLGN Stock Earnings: CollPlant Biotechnologies Meets EPS, Misses Revenue for Q1 2024 ↗

May 29, 2024

CLGN stock results show that CollPlant Biotechnologies met analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.

Via InvestorPlace

CLGN Stock Earnings: CollPlant Biotechnologies Misses EPS, Misses Revenue for Q4 2023 ↗

April 04, 2024

CLGN stock results show that CollPlant Biotechnologies missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023.

Via InvestorPlace

Earnings Scheduled For April 4, 2024 ↗

April 04, 2024

Companies Reporting Before The Bell • Conagra Brands (NYSE:CAG) is likely to report quarterly earnings at $0.65 per share on revenue of $3.01 billion.

Via Benzinga

Earnings Scheduled For November 29, 2023 ↗

November 29, 2023

Companies Reporting Before The Bell • CollPlant Biotechnologies (NASDAQ:CLGN) is likely to report quarterly loss at $0.13 per share on revenue of $3.50 million.

Via Benzinga

< Previous 1 2 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.